7th Neuroimmunology Drug Development Summit
7th Neuroimmunology Drug Development Summit | February 25-27 2025 | Boston, MA
The 7th Neuroimmunology Drug Development Summit is biopharma’s must attend forum to learn, benchmark and debate cutting edge mechanistic insights into glial biology, TREM2 and BTKi clinical learnings to optimize neuroimmunology translation and develop transformative therapeutics for neurological disorders.
With hot BTKi and TREM2 readouts transforming AD & MS treatment landscapes, and an explosion of R&D innovation from astrocyte modulation, cGAS-STING pathway and JAK-STAT immunomodulation to peripheral immune targets, inflammasome targeting, complement inhibitors and GLP-1R, the neuroinflammation field is booming with investment and fresh energy.
Where: Hilton Boston Back Bay, Boston
When: February 25-27, 2025
Program: https://ter.li/pfzfqg
This is your opportunity to join a specialized community of neuroimmunology experts, bringing together translational and clinical researchers, biomarker specialists, and industry leaders to advance neuroinflammatory and neurodegenerative drug development.
Visit the website to read more and register: https://ter.li/pdgwom
